A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial

INTRODUCTION: Critically ill patients are predisposed to venous thromboembolism. We hypothesized that higher doses of enoxaparin would improve thromboprophylaxis without increasing the risk of bleeding. Peak anti-factor Xa (anti-Xa) levels of 0.1 to 0.4 IU/ml reflect adequate thromboprophylaxis for...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Sian, Zincuk, Aleksander, Larsen, Ulla Lei, Ekstrøm, Claus, Nybo, Mads, Rasmussen, Bjarne, Toft, Palle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057520/
https://www.ncbi.nlm.nih.gov/pubmed/23601744
http://dx.doi.org/10.1186/cc12684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057520/
https://www.ncbi.nlm.nih.gov/pubmed/23601744
http://dx.doi.org/10.1186/cc12684

Ejemplares similares